Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Market price (% of par)
-
84.82%
-
Total 13F principal
-
$167,434,077
-
Principal change
-
+$1,993,150
-
Total reported market value
-
$168,923,031
-
Number of holders
-
11
-
Value change
-
-$617,814
-
Number of buys
-
3
-
Number of sells
-
7
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q2 2025
As of 30 Jun 2025,
IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 was held by
11 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$167,434,077
in principal (par value) of the bond.
The largest 10 bondholders included
BRAIDWELL LP, DeepCurrents Investment Group LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Indaba Capital Management, L.P., D. E. Shaw & Co., Inc., HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, JPMORGAN CHASE & CO, BARCLAYS PLC, Context Capital Management, LLC, and RAYMOND JAMES FINANCIAL INC.
This page lists
11
institutional bondholders reporting positions
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.